Le fabricant de gadgets santé high-tech iHealth ajoute un nouvel appareil à sa gamme déjà bien garnie : un glucomètre, qui permet aux diabétiques...
Une veille sur la santé numérique en France et à l’international : politiques publiques, données, infrastructures, IA, services et usages. Études, rapports et retours de terrain sélectionnés par Lionel Reichardt, Pharmageek, pour comprendre les transformations et éclairer les décisions.
Your new post is loading...
Your new post is loading...
Le fabricant de gadgets santé high-tech iHealth ajoute un nouvel appareil à sa gamme déjà bien garnie : un glucomètre, qui permet aux diabétiques...
Instagram fait son entrée dans le classement des 20 applications mobiles les plus utilisées en France. Actualité
Les sites sociaux, dédiés ou non à des problématiques santé, permettent d'envisager plusieurs usages de diffusion, de collecte des informations santé... Autant de modèles en train de s'élaborer et qui suscitent autant l'intérêt que le questionnement.
Via Henri Lefèvre, dbtmobile
Orange Healthcare uses its communication and integration expertise to create shared perspectives and synergies across the healthcare ecosystem.
What does the boom in digital health mean for the health care industry overall? As a new PricewaterhouseCoopers report lists the top issues in health care, we take a look the ways in which technology could shape the industry in the coming year. Via Chatu Jayadewa
Your full service research partner for ensuring improved business performance. With global capabilities including Internet-based market research enabled by our panel, Harris Poll Online Via Richard Meyer
SAMPLE PAGES-PV CORPORATE REP PHARMA-JAN 2013.pdf Download this file Increasing numbers of pharmaceutical companies are seeking to redefine their relationships with patients, recasting their companies as more patient-centric. Via rob halkes
rob halkes's curator insight,
January 14, 2013 1:55 AM
Good work from patientview ! Is it that patients exectations have risen because of having become more conscious about what pharma could do, and doesn't, or is it that pharma has fallen back in its actions to the public... ? I can see rise in pharma's social media presence and good intentions in informing the public better about their activities. But is doesn't seem enough. There's more to change of a business branche than just a facebook page. And, let'sbe honest: it is not solely about the companies; it's also about all stakeholders to the pahrma branche: authorities alike physicians..
With the kick-off of the Consumer Electronics Show (CES) this week, digital health was found to play an increasingly prominent role. From panel discussions to product launches, there was a veritable feast for the eyes and ears. During his opening... Via Philippe Marchal
CNBC.com Via Giuseppe Fattori
This is an anonymous interview with a general psychiatry consultant about her views on the pharmaceutical industry from a doctor’s perspective. (How can pharma better tailor drug information to a physician?
Le Serious Game Blog. Le Serious Game vu par GENIOUS Interactive, concepteur et producteur de Serious Games.
RT @LeemFrance: 54 nouveaux médicaments seront autorisés par l’Agence européenne (EMA) en 2013 http://t.co/YzbjAqd0 #pharma #médicament Via Hi_Camille_ |
Pour les sujets médicaux comme pour le reste, le réseau de micro-blogging contient beaucoup d’informations pertinentes. Mais trouver la bonne et les bons relais reste difficile.
With the rise of mobility in the health care industry, healthcare providers can come out ahead with mobile communication platforms that enhance patient care and lower costs. Via Dimitra Kontochristou
eHealth technologies allow doctors to access patients’ medical records more easily, get immediate access to test results from the laboratory, and deliver prescriptions directly to pharmacists, making heaçthcare delivery faster and more efficient. For patients, eHealth technologies save lives - for example, patients with heart problems can carry monitors which alert their doctor if their condition changes. Via Giuseppe Fattori
Alere’s purchase of Medapps prompts me to discuss a question posed to me daily, “What is the ROI of digital health technologies?” Discussants in the Digital Health Linkedin Group were surprised at the purchase price of ‘no greater than $22M’ for Medapps. The real issue of these technologies in my mind is not as much what the potential market is as what the ROI is. I am not going to apply economic theory or formulas in this post, as I have no formal training in economics. However, I will make this a qualitative discussion because it is a fundamental which is relevant to the adoption of such technologies, as well as furnishing some examples. Via rob halkes
rob halkes's curator insight,
January 14, 2013 4:56 AM
ROI always a tricky concept, but it need exploring..
Social Media: Part One ([HealthWorks] #SocialMedia in Healthcare: How to Harness the Marketing Opportunity http://t.co/Z0aW19jL) Via Dean Berg
This article is about the pharma industry’s need to define patient populations in order to conduct better clinical trials and develop better drugs. Via Alexandre DUBOIS
Got Game? Growth in Interactive Gaming Impacts Pharmaceutical Marketing Melodika.net (press release) Viscira, a leading provider of interactive, new-media and technology solutions for the life sciences industry, is seeing a growing demand for more...
Each of the 10 medical inventions acknowledged in our list is responsible for saving or improving the lives of patients around the world and have made their mark in medical history. Via ehealthgr
Looking at the news on Mobile Health (mHealth) technology disseminated over the Internet and other news media, one would imagine that the best devices in the mHealth sector will not be arriving until next year or by 2014. Via Emmanuel Capitaine
L’étude Print + Digital 2012 montre l’évolution rapide des habitudes de lecture de la presse en France sur les support papier et les versions numériques. Si…
To coincide with our medical communications focus month, pharmaphorum speaks with five healthcare professionals to find out how they typically engage with pharma and their thoughts on how this could be improved in the future. Via Alexandre DUBOIS |
Your new post is loading...
Ce glucomètre, enverra des données à la toute nouvelle appli iHealth appelée MyVitals, qui permet à son utilisateur d'enregistrer jusqu'à 500 indications, de noter des données de santé, de s'envoyer des rappels et de surveiller les dates de péremption des languettes de test.